Table 2.
Treatment effects
Flash monitoring | SMBG/POCT | |
---|---|---|
Patients with T1D | ||
Physiological parameters | ||
Change from baseline HbA1c at the end of year 1 (%) | 0.15 | 0.17 |
Acute event rates (per 100 patient years) | ||
NSHE | 2634 | 3550 |
SHE1 | 35.7 | 79.4 |
SHE2 | 13.8 | 30.6 |
Ketoacidosis | 1.0 | 1.4 |
Patients with T2D | ||
Physiological parameters | ||
Change from baseline HbA1c at the end of year 1 (%) | − 0.3 | − 0.3 |
Acute event rates (per 100 patient years) | ||
NSHE | 1685 | 2331 |
SHE1 | 43.9 | 92.6 |
SHE2 | 5.9 | 12.4 |
SMBG/POCT self-monitoring of blood glucose/point of care testing, T1D type 1 diabetes, T2D type 2 diabetes, NSHE non-severe hypoglycemia event, SHE1 severe hypoglycemia event grade 1 (requiring non-medical assistance), SHE2 severe hypoglycemia event grade 2 (requiring medical assistance), HbA1c glycated hemoglobin